Panel Discussion: Demonstrating Opportunity in Renal to Support a Business Case:
Time: 9:30 am
day: Day One
Speakers:
Uptal Patel is the Head of Clinical Renal and Senior Group Director in Early CVRM at AstraZeneca where he leads early clinical strategy and development for a wide range of therapies that address several kidney diseases. Previously, he led the kidney diseases domain at Gilead Sciences where he established the scientific vision and direction for…Read more
Jyothis is an entrepreneurial physician-scientist with a track-record in global leadership. Leading clinical development of BI’s cardio-metabolic portfolio (which includes two blockbusters – Empagliflozin and Linagliptin) His global outcome-trial leadership includes the pragmatic trial EXSCEL, the active-comparator trial CAROLINA, the CARMELINA trial with a renal-enriched population and the EMPEROR Heart Failure Program. This decade-long experience…Read more
